0

Tissue Microarray Market by End-user and Geography - Forecast and Analysis 2022-2026

  • Published: Nov 2021
  • Pages: 120
  • SKU: IRTNTR71521
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The tissue microarray market share is expected to increase by USD 3.14 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 7.75%.

This tissue microarray market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by end-user (hospitals, clinics, and diagnostics centers) and geography (North America, Europe, Asia, and ROW). The tissue microarray market report also offers information on several market vendors, including Agilent Technologies Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp., Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc. among others.

What will the Tissue Microarray Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Tissue Microarray Market Size for the Forecast Period and Other Important Statistics

 

Tissue Microarray Market: Key Drivers and Challenges

The growing number of cancer cases worldwide is notably driving the tissue microarray market growth, although factors such as high cost of instruments and maintenance may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the tissue microarray industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Tissue Microarray Market Driver

A rise in the number of cancer cases and the resultant R&D on cures and early diagnosis of the disease will drive the demand for tissue microarrays during the forecast period. The prevalence of cancer is increasing across the world due to various reasons, including an unhealthy diet, lack of physical activity, tobacco use, and excessive alcohol consumption. Tumor development involves simultaneous changes in thousands of cells and variations in genes. A rise in the elderly population around the globe and socio-economic risk factors are the primary factors driving the increase in the prevalence of various carcinomas. Breast cancer is among the most common cancers diagnosed among women globally. Colorectal, lung, cervical, and thyroid cancers are also common among women. This increasing number of cancer cases worldwide will fuel the growth of the tissue microarray market size.

Key Tissue Microarray Market Challenge

The high cost of instruments and maintenance may impede the tissue microarray market growth during the forecast period. Advanced tissue microarray instruments with specific and advanced features are expensive to procure and maintain, which can hinder their adoption in the market. Moreover, monitors and other portable immunodiagnostics, such as point-of-care (POC) testing products used for gene testing, must comply with the changing and periodic reviews of stringent standards and regulations which increases their maintenance costs. Thus, the high cost associated with the purchase and maintenance of these instruments is negatively affecting their adoption rate.

This tissue microarray market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Who are the Major Tissue Microarray Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Agilent Technologies Inc.
  • Arrayit Corp.
  • Bio Rad Laboratories Inc.
  • Bio Techne Corp.
  • Enzo Biochem Inc.
  • Illumina Inc.
  • Molecular Devices LLC
  • OriGene Technologies Inc.
  • PerkinElmer Inc.
  • Thermo Fisher Scientific Inc.

 

This statistical study of the tissue microarray market encompasses successful business strategies deployed by the key vendors. The tissue microarray market is concentrated and the vendors are deploying various organic and inorganic growth strategies to compete in the market.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The tissue microarray market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Tissue Microarray Market?

For more insights on the market share of various regions Request for a FREE sample now!

36% of the market’s growth will originate from North America during the forecast period. The US, Canada, and Mexico are the key markets for tissue microarray in North America. However, the market growth rate in North America will be slower than the growth of the market in Asia and Europe.

The presence of strong distribution networks in countries such as the US and Canada and the increasing focus of pharmaceutical companies on drug discovery and development will facilitate the tissue microarray market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating End-user Segments in the Tissue Microarray Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The tissue microarray market share growth by the hospitals segment will be significant during the forecast period. Tissue microarray is used for disease diagnosis in hospitals. In disease diagnosis applications, tissue microarrays have a high potential for analyzing more than thousands of tumor samples on a single slide. They also allow a high-throughput analysis of proteins and genes that can provide vital indications in cancer diagnosis. Many hospitals are required to retain archival tissue blocks for at least 20 years, and thus, the source material for tissue microarrays is readily available and is often linked to long-term outcome data. 

This report provides an accurate prediction of the contribution of all the segments to the growth of the tissue microarray market size and actionable market insights on post COVID-19 impact on each segment.

 

Tissue Microarray Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.75%

Market growth 2022-2026

$ 3.14 billion

Market structure

Concentrated

YoY growth (%)

5.71

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 36%

Key consumer countries

US, Canada, Germany, China, UK, Japan, France, India, and Mexico

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Agilent Technologies Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp., Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene Technologies Inc., PerkinElmer Inc., and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Tissue Microarray Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive tissue microarray market growth during the next five years
  • Precise estimation of the tissue microarray market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the tissue microarray industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of tissue microarray market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Executive Summary

    Market Landscape

    • Market ecosystem
    • Value chain analysis

    Market Sizing

    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026

    Five Forces Analysis

    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition

    Market Segmentation by End-user

    • Market segments
    • Comparison by End-user
    • Hospitals - Market size and forecast 2021-2026
    • Clinics - Market size and forecast 2021-2026
    • Diagnostics centers - Market size and forecast 2021-2026
    • Market opportunity by End-user

    Customer landscape

      Geographic Landscape

      • Geographic segmentation
      • Geographic comparison
      • North America - Market size and forecast 2021-2026
      • Europe - Market size and forecast 2021-2026
      • Asia - Market size and forecast 2021-2026
      • ROW - Market size and forecast 2021-2026
      • Key leading countries
      • Market opportunity by geography
      • Market drivers
      • Market challenges
      • Market trends

      Vendor Landscape

      • Vendor landscape
      • Landscape disruption

      Vendor Analysis

      • Vendors covered
      • Market positioning of vendors
      • Agilent Technologies Inc.
      • Arrayit Corp.
      • Bio Rad Laboratories Inc.
      • Bio Techne Corp.
      • Enzo Biochem Inc.
      • Illumina Inc.
      • Molecular Devices LLC
      • OriGene Technologies Inc.
      • PerkinElmer Inc.
      • Thermo Fisher Scientific Inc.

      Appendix

      • Scope of the report
      • Currency conversion rates for US$
      • Research methodology
      • List of abbreviations

      Research Framework

      Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

      TechnavioINFORMATION SOURCES

      Primary sources

      • Manufacturers and suppliers
      • Channel partners
      • Industry experts
      • Strategic decision makers

      Secondary sources

      • Industry journals and periodicals
      • Government data
      • Financial reports of key industry players
      • Historical data
      • Press releases
      Technavio

      TechnavioDATA ANALYSIS

      Data Synthesis

      • Collation of data
      • Estimation of key figures
      • Analysis of derived insights

      Data Validation

      • Triangulation with data models
      • Reference against proprietary databases
      • Corroboration with industry experts
      Technavio

      TechnavioREPORT WRITING

      Qualitative

      • Market drivers
      • Market challenges
      • Market trends
      • Five forces analysis

      Quantitative

      • Market size and forecast
      • Market segmentation
      • Geographical insights
      • Competitive landscape
      Interested in this report?
      Get your FREE sample now!
      The tissue microarray market growth will increase by $3140.09 million during 2021-2026.
      The tissue microarray market is expected to grow at a CAGR of 7.75% during 2021-2026.
      Technavio has segmented the tissue microarray market by end user (Hospitals, Clinics, and Diagnostics centers) and geographic (North America, Europe, Asia, and ROW).
      Agilent Technologies Inc., Arrayit Corp., Bio Rad Laboratories Inc., Bio Techne Corp., Enzo Biochem Inc., Illumina Inc., Molecular Devices LLC, OriGene Technologies Inc., PerkinElmer Inc., Thermo Fisher Scientific Inc. are a few of the key vendors in the tissue microarray market.
      North America will register the highest growth rate of 36.17% among the other regions. Therefore, the tissue microarray market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
      • US
      • Canada
      • Germany
      • China
      • UK
      • Japan
      • France
      • India
      • Mexico
      The key factors driving the tissue microarray market growth are:
      • Growing number of cancer cases worldwide
      The tissue microarray market vendors should focus on grabbing business opportunities from the hospitals segment as it accounted for the largest market share in the base year.
      Safe and Secure SSL Encrypted
      Technavio

      Single User:

      2500 USD

      Technavio Get the report (PDF) sent to your email within minutes.

      Subscribe & Save

      Get lifetime access to our
      Technavio Insights

      Want to customize this report?

      This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

      We offer $1000 worth of FREE customization at the time of purchase
      Technavio
      Enquire Before Buying
      1. Home
      2. Health Care
      3. Published Report
      17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>